Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib.
Journal of the European Academy of Dermatology and Venereology : JEADV(2023)
Abstract
The data that support the findings of this study are available from the corresponding author upon reasonable request.
MoreTranslated text
Key words
severe relapses,treatment
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined